<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Lipids Health Dis</journal-id><journal-id journal-id-type="iso-abbrev">Lipids Health Dis</journal-id><journal-title-group><journal-title>Lipids in Health and Disease</journal-title></journal-title-group><issn pub-type="epub">1476-511X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27161113</article-id><article-id pub-id-type="pmc">4862081</article-id><article-id pub-id-type="publisher-id">261</article-id><article-id pub-id-type="doi">10.1186/s12944-016-0261-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Maternal high fat intake affects the development and transcriptional profile of fetal intestine in late gestation using pig model</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Che</surname><given-names>Lianqiang</given-names></name><address><email>clianqiang@hotmail.com</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Peilin</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Zhengguo</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Che</surname><given-names>Long</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Liang</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Qin</surname><given-names>Linlin</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Ru</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Fang</surname><given-names>Zhengfeng</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Lin</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Shengyu</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Bin</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Jian</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>De</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><aff id="Aff1"><label/>Institute of Animal Nutrition, Sichuan Agricultural University, No.46, Xinkang Road, Ya&#x02019;an, Sichuan 625014 People&#x02019;s Republic of China </aff><aff id="Aff2"><label/>Key Laboratory for Animal Disease-Resistance Nutrition, Ministry of Education, No.46, Xinkang Road, Ya&#x02019;an, Sichuan 625014 People&#x02019;s Republic of China </aff></contrib-group><pub-date pub-type="epub"><day>10</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>15</volume><elocation-id>90</elocation-id><history><date date-type="received"><day>21</day><month>2</month><year>2016</year></date><date date-type="accepted"><day>3</day><month>5</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; Che et al. 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>The objective of this study was to investigate the effects of maternal high fat intake on intestinal development and transcriptional profile.</p></sec><sec><title>Methods</title><p>Eight gilts with similar age and body weight were randomly allocated into 2 groups receiving the control and high fat diets (HF diet) from d 30 to 90 of gestation, with 4 gilts each group and one gilt each pen. At d 90 of gestation, two fetuses each gilt were removed by cesarean section. Intestinal samples were collected for analysis of morphology, enzyme activities and transcriptional profile.</p></sec><sec><title>Results</title><p>The results showed that feeding HF diet markedly increased the fetal weight and lactase activity, also tended to increase intestinal morphology. Porcine Oligo Microarray analysis indicated that feeding HF diet inhibited 64&#x000a0;% of genes (39 genes down-regulated while 22 genes up-regulated),which were related to immune response, cancer and metabolism, also markedly modified 33 signal pathways such as antigen processing and presentation, intestinal immune network for IgA production, Jak-STAT and TGF-&#x000df; signaling transductions, pathways in colorectal cancer and glycerolipid metabolism.</p></sec><sec><title>Conclusion</title><p>Collectively, it could be concluded that maternal high fat intake was able to increase fetal weight and lactase activity, however, it altered the intestinal immune response, signal transduction and metabolism.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/s12944-016-0261-0) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Maternal nutrition</kwd><kwd>Offspring</kwd><kwd>Immune</kwd><kwd>Cancer</kwd><kwd>DNA microarray</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31101727</award-id><principal-award-recipient><name><surname>Che</surname><given-names>Lianqiang</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>Gastrointestinal tract (GIT), as an internal organ to digest nutrients and resist exogenous antigens, starts to develop at early gestation and mature rapidly in late gestation for extra-uterine life [<xref ref-type="bibr" rid="CR1">1</xref>]. The functional maturation of GIT occurs in both pre- and postnatal period, which is largely influenced by maternal nutrition [<xref ref-type="bibr" rid="CR2">2</xref>]. Maternal diet has been shown to affect the fetal development and organ function in mammalian animals [<xref ref-type="bibr" rid="CR3">3</xref>]. Our recent study also suggests that maternal nutrition levels could affect the intestinal development and function, in which maternal over-nutrition would improve intestinal morphology, enzyme activities and gene expressions of nutrient transporters in newborn pigs [<xref ref-type="bibr" rid="CR4">4</xref>]. However, it has been reported that maternal high-fat intake or &#x02013;related obesity could impair gut barrier, enhance gene expression of pro-inflammatory cytokines in offspring intestine, thus predisposes offspring to inflammatory bowel disease [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. However, the underlying mechanism for the effects of maternal high fat intake on the intestinal development and function are limited. The current study was designed to investigate the effects of maternal high fat intake on fetal intestinal development and function by measuring parameters on morphology, enzyme activities and transcriptional profiles. Oligo Microarray was used to analyze the genomic response of fetal intestine to maternal high fat intake. Pigs were chosen as the experimental animal, because it is generally accepted to be closer to humans than other laboratory or domestic animals in terms of gastrointestinal anatomy, physiology, nutrition and microbiota [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR7">7</xref>&#x02013;<xref ref-type="bibr" rid="CR9">9</xref>].</p></sec><sec id="Sec2"><title>Methods</title><p>The experimental procedure was approved by the University of Sichuan Agricultural Animal Care Advisory committee, and followed the current law of animal protection.</p><sec id="Sec3"><title>Animals and diets</title><p>A total of 8 Meishan (MS) gilts (aged at 266&#x02009;&#x000b1;&#x02009;15 d, initial body weight at 73&#x02009;&#x000b1;&#x02009;4&#x000a0;kg) were used in this study. After inseminated with MS semen, eight gilts were randomly allocated to receive control diet (CON diet with 14&#x000a0;% Protein, 34.7&#x000a0;% Starch and 2.8&#x000a0;% Fat) and high fat diet (HF diet with 14&#x000a0;% Protein, 34.7&#x000a0;% Starch and 7.3&#x000a0;% Fat), respectively. The 4.5&#x000a0;% of soy oil was added into CON diet to formulate HF diet, as a result, HF diet contained digestive energy (DE) at 3.0 Mcal/kg, while CON diet contained DE at 2.6 Mcal/kg. According to the fatty acids contents of feed ingredients by NRC (2012), the contents of saturated, mono- and polyunsaturated fatty acids were 0.25&#x000a0;%, 0.48&#x000a0;%, 0.83&#x000a0;% in CON diet and 0.84&#x000a0;%, 1.78&#x000a0;%, 3.44&#x000a0;% in HF diet, respectively. The other nutrient levels were similar between 2 diets, meeting or exceeding nutrient requirements recommended by NRC (2012). All gilts were housed individually in stall (2.5&#x000a0;m length&#x02009;&#x000d7;&#x02009;1.6&#x000a0;m width), receiving the same amount of diets at 2.0&#x000a0;kg from d 1 to 30 of gestation and 2.5&#x000a0;kg from d 30 to 90 of gestation, with free access to water. Environmental temperature was maintained at approximately 24&#x000a0;&#x000b0;C during the experiment.</p></sec><sec id="Sec4"><title>Sample collection</title><p>At d 90 of gestation, gilts were weighed (in average 128&#x000a0;kg at HF vs. 117&#x000a0;kg at CON group) and anaesthetized by intramuscularly injecting Zoletil 50 at the dose of 0.1&#x000a0;mg/kg (Virbac, France), then the uterus were removed from gilts. Two fetuses near the average fetal weight were collected each gilt. As the previous study, duodenal, jejunal and ileal samples (approximately 2&#x000a0;cm) were preserved in 4&#x000a0;% paraformaldehyde solution, then embedded in paraffin. Each tissue sample of duodenum, jejunum and ileum was used to prepare 5 slides, each slide had three sections (5&#x000a0;mm thickness), which were stained with eosin and haematoxylin, 20 well-oriented villi and crypts each section were measured for morphology (Optimus software version 6.5, Media Cybergenetics, North Reading, MA, USA), and villous height to crypt depth ratio (VCR) was calculated [<xref ref-type="bibr" rid="CR10">10</xref>]. A section of duodenum, jejunum and ileum tissues were collected and snap-frozen in liquid nitrogen, then stored at &#x02212;80&#x000a0;&#x000b0;C for analysis of enzyme activities, RNA microarray and gene expression.</p></sec><sec id="Sec5"><title>Enzyme activities</title><p>According to the previous study, the thawing samples of jejunum and ileum were weighed (approximately 2 g), then 9 times volume of 50&#x000a0;mM Tris&#x02013;HCl buffer (pH&#x000a0;7&#x02009;&#x000b7;&#x02009;0) than the sample weight were added and homogenized for 40&#x000a0;s by homogenate machine (Homogenizer Power Gen 125&#x02122;, ThermoFisher Scientific, MA, USA) and centrifuged at 3000&#x000a0;g for 10&#x000a0;min, the supernatant was collected and stored at &#x02212;20&#x000a0;&#x000b0;C [<xref ref-type="bibr" rid="CR11">11</xref>]. Total protein was extracted from the supernatant and protein concentration was determined by bicinchoninic acid protein assay with bovine serum albumin as the standard (Solarbio, Inc., Beijing, China). Activities of disaccharidase including maltase, sucrase and lactase were measured using commercial kits (Nanjing Jiancheng Bioengineering, Nanjing, China). The absorbance at 450&#x000a0;nm was determined with spectrophotometer (Beckman Coulter DU-800; Beckman Coulter, Inc., CA, USA). Activities of disaccharidase were presented as U/mg protein. One unit (U) was defined by 1&#x000a0;nmol of maltose, sucrose and lactose as a substrate for the enzymatic reaction, respectively.</p></sec><sec id="Sec6"><title>RNA extraction</title><p>The frozen ileum tissues were used for RNA extraction, 4 sections around luminal circle each tissue were collected and pooled for RNA extraction. Total RNA was extracted using Trizol reagent (Invitrogen, Carlsbad, CA, USA) and quantified using spectrophotometry based on absorbance at 260&#x000a0;nm, the RNA quality was monitored using Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). The equal amount of RNA from 2 fetus each gilt were pooled together.</p></sec><sec id="Sec7"><title>Porcine oligo microarray</title><p>As in our previous study, Agilent Porcine Oligo Microarray (4&#x02009;&#x000d7;&#x02009;44&#x000a0;K) containing more than 40,000 probes were used [<xref ref-type="bibr" rid="CR12">12</xref>]. Cyanine-3 (Cy3)-labeled cRNA was prepared from 0.5&#x000a0;&#x003bc;g RNA using the One-Color Low RNA Input Linear Amplification PLUS kit (Agilent Technologies,Palo Alto, CA, USA) according to the manufacturer&#x02019;s instructions, and followed by the RNeasy column purification (Qiagen, Valencia, CA, USA). Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer. Microarrays were hybridized at 65&#x000a0;&#x000b0;C for 17&#x000a0;h and washed with a Gene Expression Washing Buffer Kit (Agilent Technologies, Palo Alto, CA, USA). Slides were scanned with an Agilent microarray scanner.</p></sec><sec id="Sec8"><title>Microarray data collection and analysis</title><p>Microarray data were collected and analyzed using Agilent G2567AA Feature Extraction software, following Agilent&#x02019;s direct labeling protocol. The quantile method was used to normalize the probe intensities across the whole set of arrays. Three criteria were used to determine statistically significant differential expression of intestinal genes between fetus from CON and HF gilts: 1) statistical significance: <italic>P</italic> value as determined by <italic>t</italic>-test&#x02009;&#x0003c;&#x02009;0.05; 2) reliability: a spot quality flag P (&#x0201c;P,&#x0201d; a quality flag assigned by the software package); 3) relevance: a minimal fold change between the means of the 2 groups &#x0003e;1.5.</p></sec><sec id="Sec9"><title>Real-time PCR</title><p>In order to verify the microarray data, RNA samples used for porcine oligo microarray were applied to the quantitative real-time PCR (qPCR), which was performed in duplicate to amplify the target and reference genes, using one step SYBR Prime-Script&#x02122; RT-PCR kit II (Catalog no. DRR086A, Takara, Japan) by Real-Time PCR (ABI 7900HT, Applied Biosystems, CA, USA). The sequences of primers and length of products were shown at Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. The reaction mixture (10.0&#x000a0;&#x003bc;L) contained 5.6&#x000a0;&#x003bc;L of freshly pre-mixed one step SYBR Green Real-Time PCR Master mix and Prime Script&#x02122; Enzyme Mix, 0.8&#x000a0;&#x003bc;mol/L of the primers, and 100&#x000a0;ng of RNA template. The qPCR program was designed with one cycle of 42&#x000a0;&#x000b0;C for 5&#x000a0;min, one cycle of 95&#x000a0;&#x000b0;C for 10&#x000a0;s, 40&#x000a0;cycles of 95&#x000a0;&#x000b0;C for 5&#x000a0;s and 60&#x000a0;&#x000b0;C for 34&#x000a0;s, followed by the dissociation step at 95&#x000a0;&#x000b0;C for 15&#x000a0;s, 60&#x000a0;&#x000b0;C for 60&#x000a0;s and 95&#x000a0;&#x000b0;C for 15&#x000a0;s. At the end of amplification, melting curve analysis was performed to identify amplification specificity. Amplification of &#x000df;-actin was used to normalize gene expression through the double standard curves method [<xref ref-type="bibr" rid="CR11">11</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Primer sequences of genes selected for analysis by real-time RT-PCR</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Genes</th><th>GenBank accession</th><th>Primer sequence (5&#x02032;&#x02009;~&#x02009;3&#x02032;)</th><th>Product length (bp)</th><th>Tm (&#x000b0;C)</th></tr></thead><tbody><tr><td rowspan="2">HSPA1L</td><td rowspan="2">NM_001123128.1</td><td>F:CGCTTTGACCTGACTGGAAT</td><td rowspan="2">120</td><td rowspan="2">60</td></tr><tr><td>R:CTTGCCTGTGCTCTTGTCC</td></tr><tr><td rowspan="2">CD8A</td><td rowspan="2">NM_001001907.1</td><td>F:GCTGGACACCCGTTACATCT</td><td rowspan="2">100</td><td rowspan="2">60</td></tr><tr><td>R:CGAGCAGAAATAGTAGCCTTGG</td></tr><tr><td rowspan="2">CD40</td><td rowspan="2">NM_214194.1</td><td>F:GGTTCGTCTGCCTCTGAAGT</td><td rowspan="2">104</td><td rowspan="2">60</td></tr><tr><td>R:GGCTGTTTGTTGGGTATTGG</td></tr><tr><td rowspan="2">PSTPIP1</td><td rowspan="2">NM_001244186.1</td><td>F:CTCCTTTGACTCCCTGAAGC</td><td rowspan="2">114</td><td rowspan="2">60</td></tr><tr><td>R:TTCTGCCTCTCTCGGAACTC</td></tr><tr><td rowspan="2">SLA-DQA1</td><td rowspan="2">NM_001114062.2</td><td>F:TGGACCTGGAGAAGAAGGAG</td><td rowspan="2">132</td><td rowspan="2">60</td></tr><tr><td>R:TGGAGCGTTTAGTCACGATG</td></tr><tr><td rowspan="2">STAT2</td><td rowspan="2">NM_213889.1</td><td>F:TCCCAAATCACAAGGTTTCC</td><td rowspan="2">109</td><td rowspan="2">60</td></tr><tr><td>R:CAGATAGCCGAAGTCCCAAA</td></tr><tr><td rowspan="2">GK</td><td rowspan="2">NM_001143708.1</td><td>F:GCAGGTAGATGGAGGGATGA</td><td rowspan="2">107</td><td rowspan="2">60</td></tr><tr><td>R:CCAGGGCAGTTGTTTCAGG</td></tr><tr><td rowspan="2">BMP7</td><td rowspan="2">NM_001105290.1</td><td>F:TCCAGGGCAAGCACAACT</td><td rowspan="2">172</td><td rowspan="2">60</td></tr><tr><td>R:TCGGTGAGGAAGTGGCTATC</td></tr><tr><td rowspan="2">PIK3R5</td><td rowspan="2">NM_213851.1</td><td>F:CTGTCATTCCCTCCTTCCAA</td><td rowspan="2">117</td><td rowspan="2">60</td></tr><tr><td>R:GCCACCCTCCTCTTACTCTG</td></tr><tr><td rowspan="2">SLA-DRB1</td><td rowspan="2">NM_001113695.1</td><td>F:TCTGCTCTTTGTTGCTGTGG</td><td rowspan="2">120</td><td rowspan="2">60</td></tr><tr><td>R:GGATGCTTGCTTGGAGTGTC</td></tr><tr><td rowspan="2">THY1</td><td rowspan="2">XM_005667396.1</td><td>F:GGCATCGCTCTCTTGCTAAC</td><td rowspan="2">125</td><td rowspan="2">60</td></tr><tr><td>R:GGCAGGTTGGTGGTATTCTC</td></tr><tr><td rowspan="2">TGFB1</td><td rowspan="2">NM_214015.1</td><td>F:AAGCGGCAACCAAATCTATG</td><td rowspan="2">113</td><td rowspan="2">60</td></tr><tr><td>R:CCCGAGAGAGCAATACAGGT</td></tr><tr><td rowspan="2">SLA-1</td><td rowspan="2">NM_001097431.1</td><td>F:GTCAAGGAAACCGCACAGAT</td><td rowspan="2">113</td><td rowspan="2">60</td></tr><tr><td>R:CCCAAGTAGCAGCCAAACAT</td></tr><tr><td rowspan="2">CD74</td><td rowspan="2">NM_213774.1</td><td>F:ATGGACGGTGTGAACTGGA</td><td rowspan="2">100</td><td rowspan="2">60</td></tr><tr><td>R:GAACCTCAAAGGGTGTCTCCT</td></tr><tr><td rowspan="2">SOD2</td><td rowspan="2">XM_005659113.1</td><td>F:CCTTCACTTTGCCTCTTGGT</td><td rowspan="2">127</td><td rowspan="2">60</td></tr><tr><td>R:CACCGTTAGGGCTCAGATTT</td></tr><tr><td rowspan="2">ACTA2</td><td rowspan="2">XM_005671254.1</td><td>F:GTCCACCTTCCAGCAAATGT</td><td rowspan="2">105</td><td rowspan="2">60</td></tr><tr><td>R:AGACAGCGAGCAGGGTAAGT</td></tr><tr><td rowspan="2">SULT1E1</td><td rowspan="2">NM_213992.1</td><td>F:TGAAGTCTCATCTGCCACCT</td><td rowspan="2">101</td><td rowspan="2">60</td></tr><tr><td>R:AGAAACGACCACATCCTTGG</td></tr><tr><td rowspan="2">&#x003b2;-actin</td><td rowspan="2">DQ845171.1</td><td>F:GGCGCCCAGCACGAT</td><td rowspan="2">66</td><td rowspan="2">60</td></tr><tr><td>R:CCGATCCACACGGAGTACTTG</td></tr></tbody></table><table-wrap-foot><p>
<italic>HSPA1L</italic> heat shock 70&#x000a0;kDa protein 1-like, <italic>CD8A</italic> CD8a molecule (CD8A), <italic>CD40</italic> CD40 molecule, TNF receptor superfamily member 5; <italic>SLA-DQA1</italic> MHC class II histocompatibility antigen SLA-DQA, <italic>PSTPIP1</italic> proline-serine-threonine phosphatase interacting protein 1, <italic>STAT2</italic> signal transducer and activator of transcription 2, <italic>GK</italic> glycerol kinase, <italic>BMP7</italic> bone morphogenetic protein 7, <italic>PIK3R5</italic> phosphoinositide-3-kinase, regulatory subunit 5, <italic>SLA-DRB1</italic> MHC class II histocompatibility antigen SLA-DRB1, <italic>THY1</italic> Thy-1 cell surface antigen, <italic>TGFB1</italic> transforming growth factor, beta 1, <italic>SLA-1</italic> MHC class I antigen 1, <italic>CD74</italic> CD74 molecule, major histocompatibility complex, class II invariant chain, <italic>SOD2</italic> superoxide dismutase 2, mitochondrial, <italic>ACTA2</italic> actin, alpha 2, smooth muscle, aorta, <italic>SULT1E1</italic> sulfotransferase family 1E, estrogen-preferring, member 1</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec10"><title>Statistical analysis</title><p>The detected data by samples from two fetuses each gilt were averaged and taken as one independent data involving into statistical analysis model. In addition to Oligo Microarray and qPCR data, all other data on growth performance, intestinal morphology and enzyme activities were analyzed via the t Student&#x02019;s <italic>t</italic> test for a completely randomized design using SAS (SAS, Cary, NC). Results were expressed as the mean&#x02009;&#x000b1;&#x02009;SD. Differences were considered to be significant when <italic>P</italic> &#x0003c;0.05, while a tendency was considered when 0.05&#x02009;&#x0003c;&#x02009;<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.10.</p></sec></sec><sec id="Sec11"><title>Results</title><sec id="Sec12"><title>Growth performance</title><p>Feeding HF diet markedly increased the fetal weight (in average 585&#x000a0;g vs.508&#x000a0;g, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) at d 90 of gestation.</p></sec><sec id="Sec13"><title>Morphology and enzyme activities</title><p>Feeding HF diet tended to increase intestinal villous height (<italic>P</italic>&#x02009;=&#x02009;0.055), but decrease crypt depth (<italic>P</italic>&#x02009;=&#x02009;0.098) of fetus (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Meanwhile, the lactase activity was markedly increased (+55&#x000a0;%, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) by feeding HF diet relative to CON diet, whereas the maltase activity did not markedly differ between groups (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>), and sucrase activity could not be detected in fetal intestine. Gene expression of digestive enzymes were not markedly differ between two groups (Additional file <xref rid="MOESM1" ref-type="media">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Effect of maternal high fat intake on the intestinal morphology of fetus (<italic>n</italic>&#x02009;=&#x02009;4)</p></caption><graphic xlink:href="12944_2016_261_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Effects of maternal high fat intake on digestive enzyme activities of fetal intestine (<italic>n</italic>&#x02009;=&#x02009;4). The symbol &#x0201c;*&#x0201d; in figure represents there was significant difference at 5&#x000a0;% level (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05)</p></caption><graphic xlink:href="12944_2016_261_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec14"><title>Differentially expressed genes in fetal intestine</title><p>A total of 61 genes were differentially expressed (at least 1.5 fold change, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05), and 39 genes were down-regulated while 22 genes were up-regulated (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). The changes in mRNA expression detected by porcine oligo microarrays were further validated by qRT-PCR (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Given their participation in crucial biological process and modulating signal pathways on immune response, cancer and metabolism, these genes were chosen for Real-Time PCR analysis.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Maternal high fat intake markedly regulated intestinal gene expressions related to immune response, signal transduction, cancer and metabolism</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Gene Symbol<sup>a</sup>
</th><th>Gene name</th><th>Fold change<sup>b</sup>
</th><th>
<italic>P</italic> value</th></tr></thead><tbody><tr><td>CCR7</td><td>chemokine (C-C motif) receptor 7</td><td char="." align="char">&#x02212;2.94</td><td char="." align="char">0.023</td></tr><tr><td>HSPA1L</td><td>heat shock 70&#x000a0;kDa protein 1-like</td><td char="." align="char">&#x02212;2.50</td><td char="." align="char">0.016</td></tr><tr><td>CD8A</td><td>CD8a molecule (CD8A)</td><td char="." align="char">&#x02212;2.44</td><td char="." align="char">0.035</td></tr><tr><td>CD3E</td><td>CD3e molecule, epsilon (CD3-TCR complex) (CD3E)</td><td char="." align="char">&#x02212;2.27</td><td char="." align="char">0.033</td></tr><tr><td>STK17B</td><td>serine/threonine kinase 17b</td><td char="." align="char">&#x02212;2.00</td><td char="." align="char">0.026</td></tr><tr><td>CD40</td><td>CD40 molecule, TNF receptor superfamily member 5</td><td char="." align="char">&#x02212;2.00</td><td char="." align="char">0.011</td></tr><tr><td>CD2</td><td>CD2 molecule</td><td char="." align="char">&#x02212;1.89</td><td char="." align="char">0.026</td></tr><tr><td>SLA-DQA1</td><td>MHC class II histocompatibility antigen SLA-DQA</td><td char="." align="char">&#x02212;1.85</td><td char="." align="char">0.002</td></tr><tr><td>PSTPIP1</td><td>proline-serine-threonine phosphatase interacting protein 1</td><td char="." align="char">&#x02212;1.85</td><td char="." align="char">0.007</td></tr><tr><td>SLAMF6</td><td>SLAM family member 6</td><td char="." align="char">&#x02212;1.82</td><td char="." align="char">0.046</td></tr><tr><td>TP53INP1</td><td>tumor protein p53 inducible nuclear protein 1</td><td char="." align="char">&#x02212;1.82</td><td char="." align="char">0.000</td></tr><tr><td>FAM78A</td><td>family with sequence similarity 78, member A</td><td char="." align="char">&#x02212;1.79</td><td char="." align="char">0.015</td></tr><tr><td>BCL2A1</td><td>BCL2-related protein A1</td><td char="." align="char">&#x02212;1.79</td><td char="." align="char">0.023</td></tr><tr><td>ARHGAP25</td><td>Rho GTPase activating protein 25</td><td char="." align="char">&#x02212;1.75</td><td char="." align="char">0.011</td></tr><tr><td>CD1.1</td><td>CD1 antigen</td><td char="." align="char">&#x02212;1.72</td><td char="." align="char">0.007</td></tr><tr><td>STAT2</td><td>signal transducer and activator of transcription 2</td><td char="." align="char">&#x02212;1.69</td><td char="." align="char">0.042</td></tr><tr><td>ARHGAP30</td><td>Rho GTPase activating protein 30</td><td char="." align="char">&#x02212;1.69</td><td char="." align="char">0.036</td></tr><tr><td>BCL2A1</td><td>BCL2-related protein A1</td><td char="." align="char">&#x02212;1.69</td><td char="." align="char">0.040</td></tr><tr><td>IL10RB</td><td>interleukin 10 receptor, beta</td><td char="." align="char">&#x02212;1.67</td><td char="." align="char">0.013</td></tr><tr><td>GK</td><td>glycerol kinase</td><td char="." align="char">&#x02212;1.64</td><td char="." align="char">0.041</td></tr><tr><td>LTB</td><td>mRNA, clone:MLN010057G03, expressed in mesenteric lymph nodes</td><td char="." align="char">&#x02212;1.64</td><td char="." align="char">0.031</td></tr><tr><td>LCP1</td><td>lymphocyte cytosolic protein 1 (L-plastin)</td><td char="." align="char">&#x02212;1.61</td><td char="." align="char">0.014</td></tr><tr><td>PGM1</td><td>phosphoglucomutase 1</td><td char="." align="char">&#x02212;1.61</td><td char="." align="char">0.045</td></tr><tr><td>NRROS</td><td>negative regulator of reactive oxygen species</td><td char="." align="char">&#x02212;1.59</td><td char="." align="char">0.049</td></tr><tr><td>CYTH4</td><td>cytohesin 4</td><td char="." align="char">&#x02212;1.59</td><td char="." align="char">0.039</td></tr><tr><td>BMP7</td><td>bone morphogenetic protein 7</td><td char="." align="char">&#x02212;1.59</td><td char="." align="char">0.024</td></tr><tr><td>PIK3R5</td><td>phosphoinositide-3-kinase, regulatory subunit 5</td><td char="." align="char">&#x02212;1.56</td><td char="." align="char">0.009</td></tr><tr><td>RGS14</td><td>regulator of G-protein signaling 14</td><td char="." align="char">&#x02212;1.54</td><td char="." align="char">0.049</td></tr><tr><td>GLRX</td><td>glutaredoxin (thioltransferase)</td><td char="." align="char">&#x02212;1.54</td><td char="." align="char">0.025</td></tr><tr><td>SLA-DRB1</td><td>MHC class II histocompatibility antigen SLA-DRB1</td><td char="." align="char">&#x02212;1.52</td><td char="." align="char">0.028</td></tr><tr><td>LPAR2</td><td>lysophosphatidic acid receptor 2</td><td char="." align="char">&#x02212;1.52</td><td char="." align="char">0.016</td></tr><tr><td>THY1</td><td>Thy-1 cell surface antigen</td><td char="." align="char">&#x02212;1.52</td><td char="." align="char">0.028</td></tr><tr><td>TGFB1</td><td>transforming growth factor, beta 1</td><td char="." align="char">&#x02212;1.52</td><td char="." align="char">0.022</td></tr><tr><td>BAZ1A</td><td>bromodomain adjacent to zinc finger domain, 1A</td><td char="." align="char">&#x02212;1.52</td><td char="." align="char">0.024</td></tr><tr><td>CCDC69</td><td>coiled-coil domain containing 69</td><td char="." align="char">&#x02212;1.49</td><td char="." align="char">0.048</td></tr><tr><td>LRRK2</td><td>leucine-rich repeat kinase 2</td><td char="." align="char">&#x02212;1.49</td><td char="." align="char">0.022</td></tr><tr><td>SLA-1</td><td>MHC class I antigen 1</td><td char="." align="char">&#x02212;1.49</td><td char="." align="char">0.018</td></tr><tr><td>CD74</td><td>CD74 molecule, major histocompatibility complex, class II invariant chain</td><td char="." align="char">&#x02212;1.49</td><td char="." align="char">0.038</td></tr><tr><td>SOD2</td><td>superoxide dismutase 2, mitochondrial</td><td char="." align="char">1.51</td><td char="." align="char">0.004</td></tr><tr><td>ILF2</td><td>interleukin enhancer binding factor 2</td><td char="." align="char">1.51</td><td char="." align="char">0.021</td></tr><tr><td>CYP39A1</td><td>cytochrome P450, family 39, subfamily A, polypeptide 1</td><td char="." align="char">1.52</td><td char="." align="char">0.043</td></tr><tr><td>JPH4</td><td>junctophilin 4</td><td char="." align="char">1.52</td><td char="." align="char">0.026</td></tr><tr><td>ATCAY</td><td>ataxia, cerebellar, Cayman type</td><td char="." align="char">1.53</td><td char="." align="char">0.008</td></tr><tr><td>MATN2</td><td>mRNA, clone:OVR010041A03, expressed in ovary</td><td char="." align="char">1.53</td><td char="." align="char">0.016</td></tr><tr><td>CRMP1</td><td>Uncharacterized protein</td><td char="." align="char">1.54</td><td char="." align="char">0.039</td></tr><tr><td>RTDR1</td><td>mRNA, clone:UTR010010H08, expressed in uterus.</td><td char="." align="char">1.55</td><td char="." align="char">0.001</td></tr><tr><td>SPARCL1</td><td>SPARC-like 1 (hevin)</td><td char="." align="char">1.56</td><td char="." align="char">0.035</td></tr><tr><td>MATN2</td><td>mRNA, clone:OVR010041A03, expressed in ovary</td><td char="." align="char">1.56</td><td char="." align="char">0.019</td></tr><tr><td>CCN2</td><td>connective tissue growth factor</td><td char="." align="char">1.57</td><td char="." align="char">0.042</td></tr><tr><td>TUSC3</td><td>mRNA, clone: HTMT10103A12, expressed in hypothalamus</td><td char="." align="char">1.58</td><td char="." align="char">0.009</td></tr><tr><td>ID4</td><td>inhibitor of DNA binding 4, dominant negative helix-loop-helix protein</td><td char="." align="char">1.58</td><td char="." align="char">0.024</td></tr><tr><td>SPARC</td><td>secreted protein, acidic, cysteine-rich (osteonectin)</td><td char="." align="char">1.60</td><td char="." align="char">0.035</td></tr><tr><td>MEP1A</td><td>meprin A, alpha (PABA peptide hydrolase)</td><td char="." align="char">1.63</td><td char="." align="char">0.018</td></tr><tr><td>ARL10</td><td>ADP-ribosylation factor-like 10</td><td char="." align="char">1.64</td><td char="." align="char">0.036</td></tr><tr><td>STMN2</td><td>stathmin-like 2</td><td char="." align="char">1.64</td><td char="." align="char">0.039</td></tr><tr><td>ACTA2</td><td>actin, alpha 2, smooth muscle, aorta</td><td char="." align="char">1.66</td><td char="." align="char">0.016</td></tr><tr><td>SHISA2</td><td>shisa family member 2</td><td char="." align="char">1.76</td><td char="." align="char">0.029</td></tr><tr><td>UCHL1</td><td>ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)</td><td char="." align="char">1.79</td><td char="." align="char">0.014</td></tr><tr><td>OCRL</td><td>oculocerebrorenal syndrome of Lowe</td><td char="." align="char">2.01</td><td char="." align="char">0.008</td></tr><tr><td>SULT1E1</td><td>sulfotransferase family 1E, estrogen-preferring, member 1</td><td char="." align="char">2.59</td><td char="." align="char">0.013</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Genes were selected from the Kyoto Encyclopedia of Genes and Genomes pathways related to intestinal immune response, signal transduction, cancer and metabolism (<ext-link ext-link-type="uri" xlink:href="http://www.genome.jp/kegg/pathway.html">http://www.genome.jp/kegg/pathway.html</ext-link>)</p><p>
<sup>b</sup>The fold change was based on the ratio of HF group to CON group, <italic>n</italic>&#x02009;=&#x02009;4 subpools/group</p></table-wrap-foot></table-wrap><fig id="Fig3"><label>Fig. 3</label><caption><p>Heatmap of the 61 differentially expressed genes. The HF diet: s1_NS, s3-NS, s5-NS, s7-NS; The CON diet: s9_NS, s11-NS, s13-NS, s15-NS</p></caption><graphic xlink:href="12944_2016_261_Fig3_HTML" id="MO3"/></fig><table-wrap id="Tab3"><label>Table 3</label><caption><p>Differentially expressed genes in fetal intestine by maternal high fat intake and validated by qPCR</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th>Fold change<sup>b</sup>
</th><th/></tr><tr><th>Gene symbol<sup>a</sup>
</th><th>cDNA Microarray</th><th>qPCR</th><th>
<italic>P</italic> value</th></tr></thead><tbody><tr><td>ACTA2</td><td>1.66</td><td>1.10</td><td>0.246</td></tr><tr><td>SULT1E1</td><td>2.59</td><td>1.88</td><td>0.002</td></tr><tr><td>SOD2</td><td>1.51</td><td>1.75</td><td>0.036</td></tr><tr><td>BMP7</td><td>&#x02212;1.59</td><td>&#x02212;1.09</td><td>0.722</td></tr><tr><td>CD40</td><td>&#x02212;2.00</td><td>&#x02212;1.74</td><td>0.116</td></tr><tr><td>CD74</td><td>&#x02212;1.49</td><td>&#x02212;1.36</td><td>0.029</td></tr><tr><td>CD8A</td><td>&#x02212;2.44</td><td>&#x02212;1.85</td><td>0.049</td></tr><tr><td>GK</td><td>&#x02212;1.64</td><td>&#x02212;1.33</td><td>0.041</td></tr><tr><td>HSPAIL</td><td>&#x02212;2.50</td><td>&#x02212;1.60</td><td>0.027</td></tr><tr><td>PIK3R5</td><td>&#x02212;1.56</td><td>&#x02212;1.07</td><td>0.644</td></tr><tr><td>PSTPIP1</td><td>&#x02212;1.85</td><td>&#x02212;1.48</td><td>0.083</td></tr><tr><td>SLA-1</td><td>&#x02212;1.49</td><td>&#x02212;1.45</td><td>0.097</td></tr><tr><td>SLA-DQA1</td><td>&#x02212;1.85</td><td>&#x02212;1.79</td><td>0.003</td></tr><tr><td>SLA-DRB1</td><td>&#x02212;1.52</td><td>&#x02212;1.33</td><td>0.136</td></tr><tr><td>STAT2</td><td>&#x02212;1.69</td><td>&#x02212;1.18</td><td>0.125</td></tr><tr><td>TGF-&#x003b2;</td><td>&#x02212;1.52</td><td>&#x02212;1.19</td><td>0.296</td></tr><tr><td>THY1</td><td>&#x02212;1.52</td><td>&#x02212;1.29</td><td>0.118</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Genes were selected on the basis of their crucial role on regulating intestinal immune response (i.e.SLA-DRB1,SLA-DQA,HSPA1L,CD74,CD40), colorectal cancer (i.e.TGF-&#x003b2;,PIK3R5), signal transduction (i.e. PSTPIP1,BMP7,STAT2) and metabolism (i.e.GK, SULT1E1). These genes by DNA microarray were all significantly regulated (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, at least 1.5 fold change)</p><p>
<sup>b</sup>The fold change was based on the ratio of HF group to CON group, <italic>n</italic>&#x02009;=&#x02009;4 subpools/group</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec15"><title>Analysis of gene ontology and signal pathway</title><p>The differentially expressed genes were clustered according to their biological process ontology by Gene Ontology (GO) analysis from the SBS analysis system (<ext-link ext-link-type="uri" xlink:href="http://www.shanghaibiotech.com/">http://www.shanghaibiotech.com/</ext-link>). A large number of these genes were associated with antigen processing and presentation [i.e. D74, CD8A, SLA-DOB, SLA-DRB1, SLA-DQA, HSPA1L], intestinal immune network for IgA production [i.e. CD40, IL6, TGF&#x003b2;1], Jak-STAT signaling pathway [i.e. IL6, STAT2 and PIK3R5], TGF-&#x000df; signaling pathway [i.e. TGF-&#x003b2; and PIK3R5], pathways in cancer [i.e. LEF1, PIK3R5, NOS2] and glycerolipid metabolism [i.e. GK, PNLIPRP1] et al. (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>Signal pathway enrichment analysis of fetal intestine by HF diet relative to CON diet (<italic>n</italic>&#x02009;=&#x02009;4 subpools/group). The pathway terms were according to the down-regulated genes for certain biological processes, enriched categories are those identified as significantly enriched after multiple testing. * <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, ** <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01. The value by horizontal axis resulted from negative value of Log (enrichment test <italic>P</italic> value, base 10)</p></caption><graphic xlink:href="12944_2016_261_Fig4_HTML" id="MO4"/></fig></p><p>Consequently, maternal HF intake markedly modified 33 signal pathways (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01) (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>), which were mainly involved in immune response (i.e. antigen processing and presentation, intestinal immune network for IgA production, primary immunodeficiency), signaling transduction (i.e. TGF-&#x000df; signaling pathway, chemokine signaling pathway), cancer (i.e. colorectal cancer, pathways in cancer), metabolism (i.e. glycerolipid metabolism, nitrogen metabolism), signaling molecules and interaction (i.e. cytokine-cytokine receptor interaction, cell adhesion molecules, neuroactive ligand-receptor interaction).<table-wrap id="Tab4"><label>Table 4</label><caption><p>The markedly modified signal pathways in fetal intestine of gilts fed HF diet</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Name</th><th rowspan="2">Hits <sup>a</sup>
</th><th rowspan="2">Total <sup>b</sup>
</th><th rowspan="2">Percent</th><th>Enrichment test</th></tr><tr><th>
<italic>p</italic> value</th></tr></thead><tbody><tr><td>Allograft rejection</td><td>6</td><td>34</td><td>17.65&#x000a0;%</td><td>0.000</td></tr><tr><td>Antigen processing and presentation</td><td>8</td><td>64</td><td>12.50&#x000a0;%</td><td>0.000</td></tr><tr><td>Autoimmune thyroid disease</td><td>6</td><td>45</td><td>13.33&#x000a0;%</td><td>0.000</td></tr><tr><td>Cell adhesion molecules</td><td>8</td><td>71</td><td>11.27&#x000a0;%</td><td>0.000</td></tr><tr><td>Cytokine-cytokine receptor interaction</td><td>10</td><td>142</td><td>7.04&#x000a0;%</td><td>0.000</td></tr><tr><td>Hematopoietic cell lineage</td><td>7</td><td>63</td><td>11.11&#x000a0;%</td><td>0.000</td></tr><tr><td>Intestinal immune network for IgA production</td><td>7</td><td>48</td><td>14.58&#x000a0;%</td><td>0.000</td></tr><tr><td>Leishmania infection</td><td>8</td><td>63</td><td>12.70&#x000a0;%</td><td>0.000</td></tr><tr><td>Viral myocarditis</td><td>9</td><td>46</td><td>19.57&#x000a0;%</td><td>0.000</td></tr><tr><td>Graft-versus-host disease</td><td>6</td><td>57</td><td>10.53&#x000a0;%</td><td>1E-04</td></tr><tr><td>Neuroactive ligand-receptor interaction</td><td>10</td><td>174</td><td>5.75&#x000a0;%</td><td>1E-04</td></tr><tr><td>Type I diabetes mellitus</td><td>5</td><td>40</td><td>12.50&#x000a0;%</td><td>2E-04</td></tr><tr><td>Asthma</td><td>5</td><td>50</td><td>10.00&#x000a0;%</td><td>5E-04</td></tr><tr><td>Jak-STAT signaling pathway</td><td>6</td><td>82</td><td>7.32&#x000a0;%</td><td>6E-04</td></tr><tr><td>Primary immunodeficiency</td><td>4</td><td>37</td><td>10.81&#x000a0;%</td><td>0.0013</td></tr><tr><td>Pathways in cancer</td><td>7</td><td>140</td><td>5.00&#x000a0;%</td><td>0.0017</td></tr><tr><td>Hypertrophic cardiomyopathy</td><td>4</td><td>43</td><td>9.30&#x000a0;%</td><td>0.0022</td></tr><tr><td>Systemic lupus erythematosus</td><td>5</td><td>86</td><td>5.81&#x000a0;%</td><td>0.0043</td></tr><tr><td>Adipocytokine signaling pathway</td><td>4</td><td>55</td><td>7.27&#x000a0;%</td><td>0.005</td></tr><tr><td>Chemokine signaling pathway</td><td>5</td><td>90</td><td>5.56&#x000a0;%</td><td>0.0052</td></tr><tr><td>Colorectal cancer</td><td>3</td><td>31</td><td>9.68&#x000a0;%</td><td>0.0072</td></tr><tr><td>Fc gamma R-mediated phagocytosis</td><td>3</td><td>32</td><td>9.38&#x000a0;%</td><td>0.0078</td></tr><tr><td>T cell receptor signaling pathway</td><td>4</td><td>63</td><td>6.35&#x000a0;%</td><td>0.0078</td></tr><tr><td>Leukocyte transendothelial migration</td><td>4</td><td>71</td><td>5.63&#x000a0;%</td><td>0.0115</td></tr><tr><td>Acute myeloid leukemia</td><td>3</td><td>39</td><td>7.69&#x000a0;%</td><td>0.0129</td></tr><tr><td>Dilated cardiomyopathy</td><td>3</td><td>40</td><td>7.50&#x000a0;%</td><td>0.0137</td></tr><tr><td>Glycerolipid metabolism</td><td>3</td><td>41</td><td>7.32&#x000a0;%</td><td>0.0146</td></tr><tr><td>Arrhythmogenic right ventricular cardiomyopathy</td><td>3</td><td>47</td><td>6.38&#x000a0;%</td><td>0.0205</td></tr><tr><td>Nitrogen metabolism</td><td>2</td><td>19</td><td>10.53&#x000a0;%</td><td>0.0246</td></tr><tr><td>TGF-beta signaling pathway</td><td>3</td><td>55</td><td>5.45&#x000a0;%</td><td>0.0302</td></tr><tr><td>Endometrial cancer</td><td>2</td><td>22</td><td>9.09&#x000a0;%</td><td>0.0316</td></tr><tr><td>Aldosterone-regulated sodium reabsorption</td><td>2</td><td>24</td><td>8.33&#x000a0;%</td><td>0.0366</td></tr><tr><td>Type II diabetes mellitus</td><td>2</td><td>24</td><td>8.33&#x000a0;%</td><td>0.0366</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Hits mean the number of differential expressed genes within the particular GO term</p><p>
<sup>b</sup>Total: the total number of genes within the particular GO term</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec16"><title>Discussion</title><p>Some studies have indicated that maternal nutrition would affect the intestinal development and function of offspring [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR13">13</xref>&#x02013;<xref ref-type="bibr" rid="CR15">15</xref>].</p><p>In this study, maternal high fat intake increased intestinal villous height and lactase activity, which is similar as our recent study that maternal over-nutrition markedly increased birth weight, accordingly intestinal morphology as well as lactase activity [<xref ref-type="bibr" rid="CR4">4</xref>]. It may be rational that the heavier birth weight needs higher lactase activity in preparation for better degradation of lactose, which is a crucial energy source in neonatal period [<xref ref-type="bibr" rid="CR16">16</xref>]. However, a recent study indicated that maternal high fat intake would induce intestinal inflammation and poor gut barrier function in the offspring of mice [<xref ref-type="bibr" rid="CR5">5</xref>]. In this study, porcine oligo miacro array analysis was used to determine the genomic response of intestine to maternal high fat intake, in an attempt to reveal the potential mechanism. According to the strict selection criteria, we found a total of 61 genes were differentially regulated and 64&#x000a0;% of them (39 genes) was down-regulated by HF diet. With the bioinformatics analysis, these down-regulated genes were mainly involved in process of immune response, signaling transduction, pathways in cancer and metabolism, suggesting the inhibitory effects of maternal high fat intake on certain biological events. The maternal diet fat composition could change the maternal-to-fetal fatty acid transfer and intestinal membrane n-6 and n-3 fatty acids composition of newborns, thus altering intestinal function [<xref ref-type="bibr" rid="CR13">13</xref>]. In this study, therefore, it is rational that the addition of soy oil in maternal diet would induce alterations in intestinal physiology of fetus. Obviously, antigen processing and presentation in intestine could be inhibited by feeding HF diet, as indicated by the markedly decreasing gene expressions (i.e. SLA-1, SLA -DRB1, SLA-DQA1, CD74 and CD8, 1.5&#x02009;~&#x02009;2.5 fold reduction). Particularly, SLA-1, SLA -DRB1 and SLA-DQA1 are belonged to the highly polymorphic swine leucocyte antigen genes, which determine the immune response to disease and vaccine [<xref ref-type="bibr" rid="CR17">17</xref>]. Among them, SLA-1 could interact with natural killer cells to prevent cytotoxicity [<xref ref-type="bibr" rid="CR18">18</xref>], while SLA-DRB1 and -DQA1 mainly present exogenous peptides for T cells [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Previous studies have shown that maternal high fat intake impaired intestinal barrier and immune system through altering immune cell homeostasis, such as the number of T cells and macrophages [<xref ref-type="bibr" rid="CR13">13</xref>]. Furthermore, intestinal immune network for IgA production may be impaired by HF diet, as shown by the decreasing gene expression of CD40, IL-6 and TGF-&#x000df;. These genes are required for B cells proliferation and differentiation in Peyer&#x02019;s patches, their down-regulation would reduce the homing of T cells and IgA<sup>+</sup>&#x000a0;plasma cells to the intestine, thus impair the immune homeostasis of intestine [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>].</p><p>Several signal transduction pathways related to inflammatory and immune response were affected by maternal high fat intake. For example, the TGF-&#x003b2; signaling pathway was affected by HF diet, as indicated by the decreasing gene expression of TGF-&#x003b2; and Bmp7 (approximately 1.6 fold reduction). TGF-&#x003b2; is a multifunctional factor regulating cell growth, adhesion and differentiation [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>], also exerting anti-inflammatory effects by inhibiting NF-&#x003ba;B expression in the intestinal epithelium [<xref ref-type="bibr" rid="CR24">24</xref>]. The oral administration of TGF-&#x003b2; has been shown to decrease severity and incidence of necrotizing enterocolitis in neonatal rat necrotizing enterocolitis model [<xref ref-type="bibr" rid="CR24">24</xref>]. In addition, feeding HF diet affected intestinal Jak-STAT signaling pathway, as shown by the decreasing gene expression of IL6, STAT2 and PIK3R5. The Jak-STAT signaling pathway is required for T cell differentiation, B cell maturation and secretion of sIgA [<xref ref-type="bibr" rid="CR25">25</xref>], these down-regulated genes by HF diet may induce the abnormal intestinal innate immune response. Similarly, previous study demonstrated that maternal high protein diet would decrease liver mass, associated with altering gene expressions mapping to Jak-STAT signaling pathway in mouse offspring [<xref ref-type="bibr" rid="CR26">26</xref>].</p><p>Furthermore, the lower expressions of TGF-&#x003b2; and PIK3R5 genes by HF diet may affect the progression of colorectal cancer. TGF-&#x003b2;1/Smads signaling pathway was demonstrated to mediate epithelial-to-mesenchymal transition, associated with the progression of colorectal cancer [<xref ref-type="bibr" rid="CR27">27</xref>]. Mutation of PIK3R5 and other genes (i.e. PRKCZ, PTEN, RHEB and RPS6KB1) have altered PI3K signaling pathway, which is the central pathway for both colorectal and breast cancers [<xref ref-type="bibr" rid="CR28">28</xref>]. Recent studies also indicated that maternal high fat diet would modify the susceptibility to breast cancer [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>], meanwhile it is dependent on fat or oil sources [<xref ref-type="bibr" rid="CR31">31</xref>&#x02013;<xref ref-type="bibr" rid="CR33">33</xref>].</p><p>In this study, moreover, the markedly reduced glycerol kinase by feeding HF diet suggests the intestinal metabolism was altered. Glycerol kinase is required to release glycerol from glycerol-3-phosphate and dihydroxyacetone, and intestinal glycerol could produce 20&#x02009;~&#x02009;25&#x000a0;% of total endogenous glucose under insulinopenia, suggesting the important role of glycerol in intestinal metabolism [<xref ref-type="bibr" rid="CR34">34</xref>]. Although most of genes were markedly down-regulated by HF diet, some of genes (SOD2, CYP39A1, CCN2, SPARC et al.) were up-regulated. Particularly, SOD2, as an anti-oxidative enzyme in living cells, was highly expressed (1.75 fold change, <italic>P</italic>&#x02009;=&#x02009;0.04). Likewise, a recent study demonstrated that maternal high energy intake increased the expression of SOD in offspring ileum [<xref ref-type="bibr" rid="CR5">5</xref>]. Previous study indicated that the increasing SOD gene is not necessarily associated with a better antioxidant capability, for example, the inflamed intestinal mucosa has been shown to contain higher SOD protein compared with normal tissues [<xref ref-type="bibr" rid="CR35">35</xref>]. In addition, we found that feeding HF diet markedly increased gene expression of SULT1E by both DNA Microarray and RT-PCR analysis. SULT1E, as an estrogen-preferring drug metabolizing enzyme, its highly expression may be an compensatory response to high circulating estrogen, which occurs in dams fed high fat diet [<xref ref-type="bibr" rid="CR36">36</xref>]. It has been shown that the estrogen deletion by SULT1E over-expression is associated with the risk of developing different types of cancers [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR37">37</xref>].</p></sec><sec id="Sec17"><title>Conclusion</title><p>In summary, maternal high fat intake was able to increase fetal and intestinal weights as well as lactase activity, however, it altered the intestinal immune response, signal transduction and metabolism.</p></sec></body><back><app-group><app id="App1"><sec id="Sec18"><title>Additional file</title><p><media position="anchor" xlink:href="12944_2016_261_MOESM1_ESM.docx" id="MOESM1"><label>Additional file 1:</label><caption><p>Effect of maternal high fat intake on gene expression of digestive enzymes in fetal intestine. (DOCX 34 kb)</p></caption></media></p></sec></app></app-group><fn-group><fn><p><bold>Competing interests</bold></p><p>The authors declare that they have no competing interests.</p></fn><fn><p><bold>Authors&#x02019; contributions</bold></p><p>The authors&#x02019; contributions are as follows: L-QC contributed to the study design and manuscript preparation; PLL, ZGY and LC carried out the study; LH, LLQ and RW contributed to the sample analysis; ZFF, YL, JL and SYX contributed to the data analysis; BF and DW contributed to the data interpretation. All authors read and approved the final manuscript.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We would like to thank the staff at our laboratory for their ongoing assistance.</p><sec id="FPar1"><title>Funding</title><p>The present study was supported by the National Natural Science Foundation of China (31101727)&#x000a0;and&#x000a0;the National Basic Research Program (973 Program) of China (No. 2013CB127306).&#x000a0;</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Bazer</surname><given-names>FW</given-names></name><name><surname>Wallace</surname><given-names>JM</given-names></name><name><surname>Spencer</surname><given-names>TE</given-names></name></person-group><article-title>Board-invited review: intrauterine growth retardation: implications for the animal sciences</article-title><source>J Anim Sci</source><year>2006</year><volume>84</volume><fpage>2316</fpage><lpage>2337</lpage><pub-id pub-id-type="doi">10.2527/jas.2006-156</pub-id><pub-id pub-id-type="pmid">16908634</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sangild</surname><given-names>PT</given-names></name></person-group><article-title>Gut responses to enteral nutrition in preterm infants and animals</article-title><source>Exp Biol Med (Maywood)</source><year>2006</year><volume>231</volume><fpage>1695</fpage><lpage>1711</lpage><pub-id pub-id-type="pmid">17138756</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinheiro</surname><given-names>DF</given-names></name><name><surname>Pinheiro</surname><given-names>PF</given-names></name><name><surname>Buratini</surname><given-names>J</given-names><suffix>Jr</suffix></name><name><surname>Castilho</surname><given-names>AC</given-names></name><name><surname>Lima</surname><given-names>PF</given-names></name><name><surname>Trinca</surname><given-names>LA</given-names></name><name><surname>Vicentini-Paulino Mde</surname><given-names>L</given-names></name></person-group><article-title>Maternal protein restriction during pregnancy affects gene expression and immunolocalization of intestinal nutrient transporters in rats</article-title><source>Clin Sci (Lond)</source><year>2013</year><volume>125</volume><fpage>281</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1042/CS20120400</pub-id><pub-id pub-id-type="pmid">23544918</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>M</given-names></name><name><surname>Che</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Su</surname><given-names>G</given-names></name><name><surname>Fang</surname><given-names>Z</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name></person-group><article-title>Effects of maternal over- and undernutrition on intestinal morphology, enzyme activity, and gene expression of nutrient transporters in newborn and weaned pigs</article-title><source>Nutrition</source><year>2014</year><volume>30</volume><fpage>1442</fpage><lpage>1447</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2014.04.016</pub-id><pub-id pub-id-type="pmid">25280425</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Du</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>MJ</given-names></name></person-group><article-title>Maternal obesity induces gut inflammation and impairs gut epithelial barrier function in nonobese diabetic mice</article-title><source>J Nutr Biochem</source><year>2014</year><volume>25</volume><fpage>758</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2014.03.009</pub-id><pub-id pub-id-type="pmid">24775094</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Du</surname><given-names>M</given-names></name><name><surname>Hess</surname><given-names>BW</given-names></name><name><surname>Ford</surname><given-names>SP</given-names></name><name><surname>Nathanielsz</surname><given-names>PW</given-names></name><name><surname>Zhu</surname><given-names>MJ</given-names></name></person-group><article-title>Maternal obesity induces sustained inflammation in both fetal and offspring large intestine of sheep</article-title><source>Inflamm Bowel Dis</source><year>2011</year><volume>17</volume><fpage>1513</fpage><lpage>1522</lpage><pub-id pub-id-type="doi">10.1002/ibd.21539</pub-id><pub-id pub-id-type="pmid">21674707</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Bulnes</surname><given-names>A</given-names></name><name><surname>Astiz</surname><given-names>S</given-names></name><name><surname>Ovilo</surname><given-names>C</given-names></name><name><surname>Lopez-Bote</surname><given-names>CJ</given-names></name><name><surname>Sanchez-Sanchez</surname><given-names>R</given-names></name><name><surname>Perez-Solana</surname><given-names>ML</given-names></name><name><surname>Torres-Rovira</surname><given-names>L</given-names></name><name><surname>Ayuso</surname><given-names>M</given-names></name><name><surname>Gonzalez</surname><given-names>J</given-names></name></person-group><article-title>Early-postnatal changes in adiposity and lipids profile by transgenerational developmental programming in swine with obesity/leptin resistance</article-title><source>J Endocrinol</source><year>2014</year><volume>223</volume><fpage>M17</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1530/JOE-14-0217</pub-id><pub-id pub-id-type="pmid">25107535</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Widmer</surname><given-names>G</given-names></name><name><surname>Tzipori</surname><given-names>S</given-names></name></person-group><article-title>A pig model of the human gastrointestinal tract</article-title><source>Gut Microbes</source><year>2013</year><volume>4</volume><fpage>193</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.4161/gmic.23867</pub-id><pub-id pub-id-type="pmid">23549377</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinritz</surname><given-names>SN</given-names></name><name><surname>Mosenthin</surname><given-names>R</given-names></name><name><surname>Weiss</surname><given-names>E</given-names></name></person-group><article-title>Use of pigs as a potential model for research into dietary modulation of the human gut microbiota</article-title><source>Nutr Res Rev</source><year>2013</year><volume>26</volume><fpage>191</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1017/S0954422413000152</pub-id><pub-id pub-id-type="pmid">24134811</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>F</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name><name><surname>Xuan</surname><given-names>Y</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Bai</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Che</surname><given-names>L</given-names></name></person-group><article-title>Effects of high nutrient intake on the growth performance, intestinal morphology and immune function of neonatal intra-uterine growth-retarded pigs</article-title><source>Br J Nutr</source><year>2013</year><volume>110</volume><fpage>1819</fpage><lpage>1827</lpage><pub-id pub-id-type="doi">10.1017/S0007114513001232</pub-id><pub-id pub-id-type="pmid">23596997</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Xuan</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>F</given-names></name><name><surname>Tian</surname><given-names>G</given-names></name><name><surname>Fang</surname><given-names>Z</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Postnatal nutritional restriction affects growth and immune function of piglets with intra-uterine growth restriction</article-title><source>Br J Nutr</source><year>2015</year><volume>114</volume><fpage>53</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1017/S0007114515001579</pub-id><pub-id pub-id-type="pmid">26059215</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Che</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>P</given-names></name><name><surname>Mao</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name></person-group><article-title>Long-term intake of pea fiber affects colonic barrier function, bacterial and transcriptional profile in pig model</article-title><source>Nutr Cancer</source><year>2014</year><volume>66</volume><fpage>388</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1080/01635581.2014.884229</pub-id><pub-id pub-id-type="pmid">24611475</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Innis</surname><given-names>SM</given-names></name><name><surname>Dai</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Buchan</surname><given-names>AM</given-names></name><name><surname>Jacobson</surname><given-names>K</given-names></name></person-group><article-title>Perinatal lipid nutrition alters early intestinal development and programs the response to experimental colitis in young adult rats</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><year>2010</year><volume>299</volume><fpage>G1376</fpage><lpage>1385</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00258.2010</pub-id><pub-id pub-id-type="pmid">20864654</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boudry</surname><given-names>G</given-names></name><name><surname>Douard</surname><given-names>V</given-names></name><name><surname>Mourot</surname><given-names>J</given-names></name><name><surname>Lalles</surname><given-names>JP</given-names></name><name><surname>Le Huerou-Luron</surname><given-names>I</given-names></name></person-group><article-title>Linseed oil in the maternal diet during gestation and lactation modifies fatty acid composition, mucosal architecture, and mast cell regulation of the ileal barrier in piglets</article-title><source>J Nutr</source><year>2009</year><volume>139</volume><fpage>1110</fpage><lpage>1117</lpage><pub-id pub-id-type="doi">10.3945/jn.108.102640</pub-id><pub-id pub-id-type="pmid">19403717</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desaldeleer</surname><given-names>C</given-names></name><name><surname>Ferret-Bernard</surname><given-names>S</given-names></name><name><surname>de Quelen</surname><given-names>F</given-names></name><name><surname>Le Normand</surname><given-names>L</given-names></name><name><surname>Perrier</surname><given-names>C</given-names></name><name><surname>Savary</surname><given-names>G</given-names></name><name><surname>Rome</surname><given-names>V</given-names></name><name><surname>Michel</surname><given-names>C</given-names></name><name><surname>Mourot</surname><given-names>J</given-names></name><name><surname>Le Huerou-Luron</surname><given-names>I</given-names></name><name><surname>Boudry</surname><given-names>G</given-names></name></person-group><article-title>Maternal 18:3n-3 favors piglet intestinal passage of LPS and promotes intestinal anti-inflammatory response to this bacterial ligand</article-title><source>J Nutr Biochem</source><year>2014</year><volume>25</volume><fpage>1090</fpage><lpage>1098</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2014.05.014</pub-id><pub-id pub-id-type="pmid">25087993</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heyman</surname><given-names>MB</given-names></name><collab>Committee on N</collab></person-group><article-title>Lactose intolerance in infants, children, and adolescents</article-title><source>Pediatrics</source><year>2006</year><volume>118</volume><fpage>1279</fpage><lpage>1286</lpage><pub-id pub-id-type="doi">10.1542/peds.2006-1721</pub-id><pub-id pub-id-type="pmid">16951027</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>CS</given-names></name><name><surname>Lunney</surname><given-names>JK</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Franzo-Romain</surname><given-names>MH</given-names></name><name><surname>Martens</surname><given-names>GW</given-names></name><name><surname>Rowland</surname><given-names>RR</given-names></name><name><surname>Smith</surname><given-names>DM</given-names></name></person-group><article-title>Molecular characterization of swine leucocyte antigen class II genes in outbred pig populations</article-title><source>Anim Genet</source><year>2010</year><volume>41</volume><fpage>428</fpage><lpage>432</lpage><pub-id pub-id-type="pmid">20121817</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lunney</surname><given-names>JK</given-names></name><name><surname>Ho</surname><given-names>CS</given-names></name><name><surname>Wysocki</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>DM</given-names></name></person-group><article-title>Molecular genetics of the swine major histocompatibility complex, the SLA complex</article-title><source>Dev Comp Immunol</source><year>2009</year><volume>33</volume><fpage>362</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2008.07.002</pub-id><pub-id pub-id-type="pmid">18760302</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Summerfield</surname><given-names>A</given-names></name><name><surname>Guzylack-Piriou</surname><given-names>L</given-names></name><name><surname>Schaub</surname><given-names>A</given-names></name><name><surname>Carrasco</surname><given-names>CP</given-names></name><name><surname>Tache</surname><given-names>V</given-names></name><name><surname>Charley</surname><given-names>B</given-names></name><name><surname>McCullough</surname><given-names>KC</given-names></name></person-group><article-title>Porcine peripheral blood dendritic cells and natural interferon-producing cells</article-title><source>Immunology</source><year>2003</year><volume>110</volume><fpage>440</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2567.2003.01755.x</pub-id><pub-id pub-id-type="pmid">14632641</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Dubois</surname><given-names>RN</given-names></name><name><surname>Richmond</surname><given-names>A</given-names></name></person-group><article-title>The role of chemokines in intestinal inflammation and cancer</article-title><source>Curr Opin Pharmacol</source><year>2009</year><volume>9</volume><fpage>688</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1016/j.coph.2009.08.003</pub-id><pub-id pub-id-type="pmid">19734090</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>VT</given-names></name><name><surname>Beller</surname><given-names>A</given-names></name><name><surname>Rausch</surname><given-names>S</given-names></name><name><surname>Strandmark</surname><given-names>J</given-names></name><name><surname>Zanker</surname><given-names>M</given-names></name><name><surname>Arbach</surname><given-names>O</given-names></name><name><surname>Kruglov</surname><given-names>A</given-names></name><name><surname>Berek</surname><given-names>C</given-names></name></person-group><article-title>Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis</article-title><source>Immunity</source><year>2014</year><volume>40</volume><fpage>582</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.02.014</pub-id><pub-id pub-id-type="pmid">24745334</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massagu&#x000e9;</surname><given-names>J</given-names></name></person-group><article-title>TGF&#x003b2; in cancer</article-title><source>Cell</source><year>2008</year><volume>134</volume><fpage>215</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.07.001</pub-id><pub-id pub-id-type="pmid">18662538</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">Van&#x02019;t Land B, Meijer H, Frerichs J, Koetsier M, Jager D, Smeets R, M'Rabet L, Hoijer M. Transforming Growth Factor-&#x003b2;2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling. Br J Cancer. 2002;87:113&#x02013;8.</mixed-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiou</surname><given-names>SR</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Westerhoff</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Petrof</surname><given-names>EO</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Claud</surname><given-names>EC</given-names></name></person-group><article-title>Oral administration of transforming growth factor-beta1 (TGF-beta1) protects the immature gut from injury via Smad protein-dependent suppression of epithelial nuclear factor kappaB (NF-kappaB) signaling and proinflammatory cytokine production</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><fpage>34757</fpage><lpage>34766</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.503946</pub-id><pub-id pub-id-type="pmid">24129565</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heneghan</surname><given-names>AF</given-names></name><name><surname>Pierre</surname><given-names>JF</given-names></name><name><surname>Kudsk</surname><given-names>KA</given-names></name></person-group><article-title>JAK-STAT and intestinal mucosal immunology</article-title><source>JAKSTAT</source><year>2013</year><volume>2</volume><fpage>e25530</fpage><pub-id pub-id-type="pmid">24416649</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanselow</surname><given-names>J</given-names></name><name><surname>Kucia</surname><given-names>M</given-names></name><name><surname>Langhammer</surname><given-names>M</given-names></name><name><surname>Koczan</surname><given-names>D</given-names></name><name><surname>Rehfeldt</surname><given-names>C</given-names></name><name><surname>Metges</surname><given-names>CC</given-names></name></person-group><article-title>Hepatic expression of the GH/JAK/STAT/IGF pathway, acute-phase response signalling and complement system are affected in mouse offspring by prenatal and early postnatal exposure to maternal high-protein diet</article-title><source>Eur J Nutr</source><year>2011</year><volume>50</volume><fpage>611</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1007/s00394-011-0168-5</pub-id><pub-id pub-id-type="pmid">21290249</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Sui</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name></person-group><article-title>Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-&#x003b2;1/Smads signaling pathway mediated Snail/E-cadherin expression</article-title><source>BMC Cancer</source><year>2015</year><volume>15</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.1186/1471-2407-15-1</pub-id><pub-id pub-id-type="pmid">25971837</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>LD</given-names></name><name><surname>Parsons</surname><given-names>DW</given-names></name><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Sj&#x000f6;blom</surname><given-names>T</given-names></name><name><surname>Leary</surname><given-names>RJ</given-names></name><name><surname>Shen</surname><given-names>D</given-names></name><name><surname>Boca</surname><given-names>SM</given-names></name><name><surname>Barber</surname><given-names>T</given-names></name><name><surname>Ptak</surname><given-names>J</given-names></name></person-group><article-title>The genomic landscapes of human breast and colorectal cancers</article-title><source>Science</source><year>2007</year><volume>318</volume><fpage>1108</fpage><lpage>1113</lpage><pub-id pub-id-type="doi">10.1126/science.1145720</pub-id><pub-id pub-id-type="pmid">17932254</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montales</surname><given-names>MT</given-names></name><name><surname>Melnyk</surname><given-names>SB</given-names></name><name><surname>Simmen</surname><given-names>FA</given-names></name><name><surname>Simmen</surname><given-names>RC</given-names></name></person-group><article-title>Maternal metabolic perturbations elicited by high-fat diet promote Wnt-1-induced mammary tumor risk in adult female offspring via long-term effects on mammary and systemic phenotypes</article-title><source>Carcinogenesis</source><year>2014</year><volume>35</volume><fpage>2102</fpage><lpage>2112</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgu106</pub-id><pub-id pub-id-type="pmid">24832086</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Oliveira</surname><given-names>AF</given-names></name><name><surname>Fontelles</surname><given-names>CC</given-names></name><name><surname>Rosim</surname><given-names>MP</given-names></name><name><surname>de Oliveira</surname><given-names>TF</given-names></name><name><surname>de Melo Loureiro</surname><given-names>AP</given-names></name><name><surname>Mancini-Filho</surname><given-names>J</given-names></name><name><surname>Rogero</surname><given-names>MM</given-names></name><name><surname>Moreno</surname><given-names>FS</given-names></name><name><surname>de Assis</surname><given-names>S</given-names></name><name><surname>Barbisan</surname><given-names>LF</given-names></name><etal/></person-group><article-title>Exposure to lard-based high-fat diet during fetal and lactation periods modifies breast cancer susceptibility in adulthood in rats</article-title><source>J Nutr Biochem</source><year>2014</year><volume>25</volume><fpage>613</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2013.10.006</pub-id><pub-id pub-id-type="pmid">24746835</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mabasa</surname><given-names>L</given-names></name><name><surname>Cho</surname><given-names>K</given-names></name><name><surname>Walters</surname><given-names>MW</given-names></name><name><surname>Bae</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>CS</given-names></name></person-group><article-title>Maternal dietary canola oil suppresses growth of mammary carcinogenesis in female rat offspring</article-title><source>Nutr Cancer</source><year>2013</year><volume>65</volume><fpage>695</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1080/01635581.2013.789539</pub-id><pub-id pub-id-type="pmid">23859037</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czuba</surname><given-names>AK</given-names></name><name><surname>Mazurkiewicz</surname><given-names>M</given-names></name><name><surname>Stanimirova-Daszykowska</surname><given-names>I</given-names></name></person-group><article-title>Enrichment of maternal diet with conjugated linoleic acids influences desaturases activity and fatty acids profile in livers and hepatic microsomes of the offspring with 7, 12-dimethylbenz [a] anthracene-induced mammary tumors</article-title><source>Acta Pol Pharm</source><year>2014</year><volume>71</volume><fpage>747</fpage><pub-id pub-id-type="pmid">25362803</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>H-M</given-names></name><name><surname>Hsieh</surname><given-names>P-H</given-names></name><name><surname>Chen</surname><given-names>H-F</given-names></name></person-group><article-title>A maternal high n-6 fat diet with fish oil supplementation during pregnancy and lactation in rats decreases breast cancer risk in the female offspring</article-title><source>J Nutr Biochem</source><year>2010</year><volume>21</volume><fpage>1033</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2009.08.007</pub-id><pub-id pub-id-type="pmid">19954943</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croset</surname><given-names>M</given-names></name><name><surname>Rajas</surname><given-names>F</given-names></name><name><surname>Zitoun</surname><given-names>C</given-names></name><name><surname>Hurot</surname><given-names>J-M</given-names></name><name><surname>Montano</surname><given-names>S</given-names></name><name><surname>Mithieux</surname><given-names>G</given-names></name></person-group><article-title>Rat small intestine is an insulin-sensitive gluconeogenic organ</article-title><source>Diabetes</source><year>2001</year><volume>50</volume><fpage>740</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.2337/diabetes.50.4.740</pub-id><pub-id pub-id-type="pmid">11289037</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruidenier</surname><given-names>L</given-names></name><name><surname>Kuiper</surname><given-names>I</given-names></name><name><surname>van Duijn</surname><given-names>W</given-names></name><name><surname>Marklund</surname><given-names>SL</given-names></name><name><surname>van Hogezand</surname><given-names>RA</given-names></name><name><surname>Lamers</surname><given-names>CB</given-names></name><name><surname>Verspaget</surname><given-names>HW</given-names></name></person-group><article-title>Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease</article-title><source>J Pathol</source><year>2003</year><volume>201</volume><fpage>7</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1002/path.1407</pub-id><pub-id pub-id-type="pmid">12950012</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilakivi-Clarke</surname><given-names>L</given-names></name><name><surname>Clarke</surname><given-names>R</given-names></name><name><surname>Onojafe</surname><given-names>I</given-names></name><name><surname>Raygada</surname><given-names>M</given-names></name><name><surname>Cho</surname><given-names>E</given-names></name><name><surname>Lippman</surname><given-names>M</given-names></name></person-group><article-title>A maternal diet high in n&#x02009;&#x02212;&#x02009;6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring</article-title><source>Proc Natl Acad Sci</source><year>1997</year><volume>94</volume><fpage>9372</fpage><lpage>9377</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.17.9372</pub-id><pub-id pub-id-type="pmid">9256489</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharda</surname><given-names>DR</given-names></name><name><surname>Miller-Lee</surname><given-names>JL</given-names></name><name><surname>Kanski</surname><given-names>GM</given-names></name><name><surname>Hunter</surname><given-names>JC</given-names></name><name><surname>Lang</surname><given-names>CH</given-names></name><name><surname>Kennett</surname><given-names>MJ</given-names></name><name><surname>Korzick</surname><given-names>DH</given-names></name></person-group><article-title>Comparison of the agar block and Lieber&#x02013;DeCarli diets to study chronic alcohol consumption in an aging model of Fischer 344 female rats</article-title><source>J Pharmacol Toxicol Methods</source><year>2012</year><volume>66</volume><fpage>257</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/j.vascn.2012.08.166</pub-id><pub-id pub-id-type="pmid">22951285</pub-id></element-citation></ref></ref-list></back></article>